Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1425927 | Journal of Controlled Release | 2010 | 12 Pages |
The purpose of this study is to evaluate in vitro and in vivo gene delivery efficiency of polyamidoamine (PAMAM) starburst dendrimer (generation 2, G2) conjugates with α-cyclodextrin (α-CDE (G2)) bearing lactose (Lac-α-CDE) with various degrees of substitution of the lactose moiety (DSL) as a novel hepatocyte-selective carrier in hepatocytes. Lac-α-CDE (DSL 2.6) was found to have much higher gene transfer activity than dendrimer, α-CDE, Lac-α-CDE (DSL 1.2, 4.6, 6.2 and 10.2) and lactosylated dendrimer (Lac-dendrimer, DSL 2.4) in HepG2 cells, which are dependent on the expression of cell-surface asialoglycoprotein receptor (ASGP-R), reflecting the cellular association of the plasmid DNA (pDNA) complexes. The physicochemical properties of pDNA complex with Lac-α-CDE (DSL 2.6) were almost comparable to that with α-CDE. Lac-α-CDE (DSL 2.6) provided negligible cytotoxicity up to a charge ratio of 150 in HepG2 cells. Lac-α-CDE (DSL 2.6) provided gene transfer activity higher than jetPEITM-Hepatocyte to hepatocytes with much less changes of blood chemistry values 12 h after intravenous administration in mice. These results suggest the potential use of Lac-α-CDE (DSL 2.6) as a non-viral vector for gene delivery toward hepatocytes.
Graphical abstractFigure optionsDownload full-size imageDownload as PowerPoint slide